CVS Health trumpets standing during Analyst Day

Strategies for long-term growth and shareholder value were discussed at the most recent Analyst Day.
Strategies for long-term growth and shareholder value were discussed at the most recent Analyst Day. | File photo
CVS Health recently held its annual Analyst Day, a meeting in which the discussions of strategies for long-term growth will be driven and shareholder value were held.
CVS Health President and CEO Larry Merlo opened the meeting by speaking to those in attendance.
“By making care more affordable, accessible and effective, we can deliver value to all health care stakeholders, allowing us to be a partner of choice as they look to achieve their health care goals,” Merlo said. “Despite all the changes happening in health care, success will ultimately be determined by how effective you are at executing on these three objectives. And we remain confident that CVS Health is well-positioned to deliver on all three." Merlo said CVS Health continues to have the most extensive suite of enterprise assets that on a standalone basis would each be market-leading. Largely through technology, CVS Health can integrate pharmacy care from the payer to the provider to the patient.
During the meeting, Executive Vice President and Chief Financial Officer Dave Denton summarized the 2016 and 2017 expectations for CVS Health, as well as a review of long-term growth targets and maximizing shareholder value.